VC Funds Starting with D

Deep Blue Ventures (DBV) is Italy's first deep tech venture capital fund focused on Rome, launched in 2023 and managed by Deep Ocean Capital SGR S.p.A. The fund closed its first tranche at EUR 40.8 million against a EUR 70 million target, backed by cornerstone investors including the European Investment Fund (EIF), CDP Venture Capital SGR, Blue Ocean Finance, and ReItaly21 — a coalition that reflects DBV's ambition to anchor Rome in the European deep tech map. The fund leads at seed stage, with selective Series A participation. DBV deploys EUR 500,000 to EUR 2.5 million per investment, targeting exponential technologies including artificial intelligence, quantum computing, photonics, cybersecurity, synthetic biology, and advanced materials applied to strategic sectors such as aerospace, healthcare, and sustainability. The portfolio of 7 investments — completed within the first 18 months of operation — includes AI4IV in neuromorphic computing, OhmSpace in aerospace, PhotonPath in semiconductor photonics, Genoa Instruments in super-resolution microscopy, and Random Power in quantum randomness. Key institutional partners include Leonardo, the European Space Agency, I3P incubator at Politecnico di Torino, the Italian Institute of Technology, and the National Research Council. DBV is led by Chairman and Co-Founder Emilia Garito, CEO and Co-Founder Domenico Nesci, and Chief Investment Officer Paolo Cellini. The firm operates a Deep Tech Factory Model that combines venture capital with venture building to accelerate the de-risking of breakthrough technologies from Italian and European research institutions into scalable commercial ventures.

Deep Fork Capital (DFC) is an early-stage venture capital firm founded in 2007 and based in San Francisco. The fund focuses on investing in disruptive, technology-driven startups primarily within the consumer internet, digital media, and enterprise software spaces. Key sectors include adtech, e-commerce, big data, and cloud computing. DFC is particularly interested in entrepreneurs who are data-driven and building platform-based businesses with strong network effects. With investments ranging from $0.5M to $10M, Deep Fork Capital partners with startups at the seed and early stages, providing both equity capital and convertible debt financing. Their portfolio includes notable companies like BigID, SaltStack, Trulia, and Dataminr, many of which have achieved successful exits or acquisitions. The firm's co-investors include major players such as Bessemer Venture Partners and Comcast Ventures. Led by experienced founders and investors, including Timothy Komada, Deep Fork Capital takes a hands-on approach, leveraging its global network to support the growth and success of its portfolio companies across multiple platforms and geographies.

Deep Future is a venture capital firm focused on investing in advanced, transformative technologies, often referred to as "deep tech." Founded in 2021, the firm targets early-stage startups that tackle complex, high-impact problems. Their mission is to back visionary inventors and entrepreneurs working on innovations that seem like science fiction but hold the potential to significantly advance industries. Deep Future invests in sectors like AI, semiconductors, sustainable manufacturing, and clean energy. Notable investments include projects like pollution-to-profit systems, autonomous ships powered by renewable energy, and advanced semiconductor technologies. They typically lead or participate in pre-seed rounds with check sizes ranging from $200k to $500k, and focus on companies that are still in the ideation or prototype phase. The firm, headquartered in Seattle, is spearheaded by Pablos Holman, a well-known futurist and inventor. Deep Future has built a portfolio around ambitious technologies, such as space-based solar power and non-toxic processes for extracting precious metals from electronic waste.

Deep Science Ventures (DSV) is a London-based venture studio founded in 2016 that specializes in building science-driven startups across four key sectors: agriculture, computation, climate, and pharmaceuticals. DSV's approach is unique in that it combines scientific knowledge with entrepreneurial expertise to create high-impact ventures from scratch. They partner closely with founder-scientists to tackle some of the world's most pressing challenges, such as reversing global warming, developing curative therapeutics, and advancing computational technologies. DSV's portfolio includes a diverse range of companies, such as Mission Zero Technologies, which focuses on energy-efficient direct air capture of CO2, and Neobe Therapeutics, which is engineering bacteria to improve the efficacy of cancer immunotherapy. These ventures reflect DSV's commitment to creating transformative solutions that are both scientifically rigorous and commercially viable. The firm's model emphasizes de-risking ventures through deep technical and market analysis before significant capital is committed. This methodical approach ensures that the startups they create have a strong foundation for long-term success.

Deep Space Ventures was a Dallas, Texas-based venture capital firm founded in March 2016 by Stephen Hays, a former Wall Street investment banker with over six years of experience in capital raising and M&A advisory. The fund was launched to capitalize on the reallocation of capital from Texas's declining oil and gas sector into a growing technology ecosystem, with a geographic preference for the Dallas-Fort Worth region and a broader national reach. Deep Space invested in seed and Series A stage startups across esports, B2B SaaS, and fintech, with 12 total investments and 10 concentrated in Texas. The firm led rounds and wrote checks in the $500,000 to $1 million range, deploying approximately $1.75 million in its early months across 22 tracked investments. Portfolio companies included Vinli in connected car technology, Panamplify in software analytics, Selery Fulfillment, CounterFind, Legalinc, OpTic Gaming, and Infinite Esports & Entertainment. The fund reported a net IRR of 17.15% and an investment multiple of 3.18x, with a 2.5% management fee and 20% carried interest. Fund operations effectively ceased in August 2018 following the arrest of managing partner Stephen Hays. Hays subsequently founded What If Ventures in January 2020, a separate fund focused on mental health and addiction-related startups. Deep Space Ventures represents a brief but notable chapter in the development of Dallas's early-stage technology investment ecosystem during a period when Texas was diversifying its capital base beyond energy.

Deep30 is a Tokyo-based venture capital firm established in 2018, specializing in artificial intelligence (AI) and deep learning technologies. The fund primarily targets early-stage startups that leverage cutting-edge AI applications to transform industries, offering them both financial backing and hands-on technical expertise. Deep30 works closely with companies connected to research institutions like the University of Tokyo's Matsuo Lab, renowned for its AI research. The firm focuses on industries such as machine learning, data analytics, and AI-driven software. Notable investments include DeepCraft and IntegrAI, showcasing their commitment to advancing AI solutions across sectors like healthcare, IoT, and enterprise software. Deep30 typically invests in seed and early-stage rounds, with an average round size of $8 million, supporting companies in Japan and globally. Led by CEO Tomofuku Kawakami, Deep30 provides a comprehensive support structure, including business planning and networking opportunities. This approach has led to successful exits, such as Neural Pocket through an IPO and Stathack via acquisition. Deep30 is well-positioned as a key player in fostering the next wave of AI-driven innovations in Japan and beyond.

Deepbridge Capital, established in 2010 and headquartered in Chester, UK, focuses on providing growth capital to companies in the technology, life sciences, and renewable energy sectors. Their investment approach emphasizes supporting innovative and high-growth potential companies through various tax-efficient investment opportunities. Deepbridge Capital's portfolio includes a diverse array of companies. Notable investments are in firms like AlgaeCytes, which specializes in producing high-quality EPA oils from algae, and VoxSmart, which provides compliance management solutions for banks. They have also invested in promising startups like Thalia Design Automation, an AI-driven EDA platform, and Ibis Vision, a cloud-based vision testing software for the optical industry. The firm has made 168 investments and has seen 101 exits, showcasing their experience and success in nurturing companies to achieve significant milestones. Deepbridge Capital also supports companies through initiatives such as the Deepbridge Technology Growth EIS Fund and the Deepbridge Innovation SEIS Fund, offering financial backing and strategic guidance to early-stage businesses. The Deepbridge team, led by Managing Partner Ian Warwick, is known for their commitment to fostering innovation and growth across their investment sectors. For more information about their investments and strategic approach, you can visit their official website.

The DeepTech & Climate Fonds (DTCF) is a German venture capital fund aimed at supporting growth-stage startups working on transformative technologies in sectors such as deep tech and climate tech. Established in 2023, the fund has a capital pool of €1 billion, sourced from Germany’s Future Fund and the European Recovery Program. It focuses on companies developing solutions in fields like Industry 4.0, quantum computing, AI, and clean energy technologies. DTCF primarily invests in companies that require long development cycles and substantial capital, providing them with the resources to scale their innovations across Europe. The fund works as an anchor investor, partnering with institutional investors, family offices, and private capital to ensure that these companies can achieve commercial success and contribute to a climate-neutral economy. Led by Dr. Elisabeth Schrey and Tobias Faupel, DTCF has already made notable investments in companies like Membion, which focuses on wastewater recycling, and Cylib, a battery recycling startup. The fund's mission is to drive systemic change by investing in technologies that will reshape industries and contribute to sustainability across the European tech landscape​.

Deeptech Seed Fund is a Dublin-based venture capital firm focused on supporting early-stage deep-tech startups across Europe. Established by Pearse Coyle in 2018, the fund specifically targets ventures that have achieved significant scientific or technological breakthroughs and are starting to demonstrate global market potential. Their focus spans a broad array of sectors, including artificial intelligence, blockchain, robotics, sustainability, and IoT, although they avoid investments in life sciences​. The fund operates with an investment thesis built around market validation. Before committing capital, Deeptech Seed Fund ensures that startups have connected with potential customers and obtained valuable feedback. They then collaborate with international later-stage investors to provide these promising ventures with robust follow-on funding. This approach ensures startups receive the right type of funding from the beginning, positioning them for long-term success in global markets​. With investments typically starting at $100,000, Deeptech Seed Fund takes an active role in helping startups commercialize their innovations. Notable companies in their portfolio include Qoitech, a Swedish company developing energy optimization solutions, and Signapse, which specializes in AI-driven real-time sign language translation. The fund also emphasizes deep partnerships with incubators and innovation programs to scout cutting-edge research-based spinouts, further nurturing the commercialization of scientific advancements. By providing both capital and strategic support, Deeptech Seed Fund is instrumental in helping European deep-tech startups bridge the gap between research and market.

DeepTech Ventures is an early-stage venture capital firm headquartered in Pfaffikon, Switzerland, founded in 2018. The firm is an investment pioneer in the Web3 space, backing protocols, networks, and infrastructure projects across the full decentralized technology stack. Led by founder Alexander Christen — CEO of FiveT Fintech and formerly of Partners Group and SIX Swiss Exchange — alongside Managing Partner Daniel Curiger (ex-Goldman Sachs and UBS) and Crypto Research Analyst Florian Bitterli, the seven-person team brings deep roots in software development, finance, and economics. With 59 investments to date and typical check sizes between $100,000 and $1 million, DeepTech Ventures participates across blockchain, DeFi, NFTs, and DAO governance. The portfolio spans Layer 0/1 networks including Ethereum, Cosmos, Polkadot, Solana, and Avalanche; DeFi protocols such as Uniswap, Convex Finance, Curve, and Yearn Finance; NFT platforms including Decentraland and SuperRare; and infrastructure projects such as Lido, TheGraph, Arweave, and Filecoin. The firm takes an unusually active role in its investments beyond capital, engaging in governance voting, liquidity provision, keeper operations, and node operation within portfolio ecosystems. Investment instruments span equity, tokens, SAFEs, and SAFTs, giving the team flexibility to enter at the structure that best fits each project. The result is a fund deeply embedded in the ecosystems it backs rather than a passive observer.

DeepWork Capital, established in 2015 and based in Orlando, Florida, is an early-stage venture capital firm. The firm primarily targets technology and life sciences startups, particularly those in U.S. regions traditionally underserved by venture capital. DeepWork Capital's investment strategy focuses on seed and Series A stage companies, often being the first institutional capital after friends, family, and angel investors. Their portfolio includes a diverse range of companies such as AbFero Pharmaceuticals, acquired by Pharmacosmos, and AireHealth, addressing respiratory challenges. Other notable investments include Astrocyte Pharmaceuticals, developing therapeutics for brain injury, and Genascence, working on gene therapy for musculoskeletal diseases. The firm also supports innovative startups like Nanophotonica, which is pioneering EL-QLED technology, and Homee, which digitizes insurance claims processes. The DeepWork Capital team, including Managing Partners Mitchel Laskey, Ben Patz, and Kathy Chiu, brings a wealth of experience from various industries. The firm emphasizes a hands-on, active engagement approach, supporting entrepreneurs before, during, and after investment. DeepWork Capital's mission is to foster innovation in regions like Florida by providing necessary capital and strategic support to tech-forward founders committed to solving significant societal challenges.

Deerfield Management, a prominent investment firm based in New York City, is dedicated to advancing healthcare through strategic investments, information, and philanthropy. With over $14.6 billion in assets under management, Deerfield maintains a diverse portfolio of more than 200 private and public investments across biotechnology, pharmaceuticals, medical devices, healthcare services, and digital health industries​ . Notable portfolio companies include Graphcore, JFrog, and Netskope. The firm has a strong track record of supporting startups from early stages to mature companies, offering flexible funding models, including equity, debt, and joint ventures. Deerfield’s investment approach is characterized by deep operational support and a robust network of strategic partners and academic collaborations​ ​. Deerfield’s team comprises over 150 experienced professionals with expertise in various sectors of healthcare and finance, ensuring comprehensive support for their portfolio companies. The firm’s initiatives, such as the Deerfield Discovery and Development (3DC) and the Cure Campus, further highlight their commitment to fostering innovation and addressing complex health issues​​. The Deerfield Foundation, part of the firm’s philanthropic efforts, focuses on improving healthcare delivery, particularly for underserved populations, and has invested over $68 million in various health initiatives.

Define Ventures is a premier early-stage venture capital firm, singularly focused on investing in digital health companies. With a keen eye for transformative potential, Define Ventures partners with innovative entrepreneurs to reshape the healthcare landscape. Their portfolio features notable investments such as Blackbird Health, which is revolutionizing pediatric mental health, and Lightship, a pioneer in decentralized clinical trials. Define Ventures operates primarily within the digital health sector, focusing on business models that integrate technology and healthcare to create scalable solutions. Geographically, they concentrate their efforts within the United States, fostering close relationships with startups that promise substantial impact in the national healthcare system. The firm’s strategy centers on leading early-stage funding rounds, including incubation, seed, Series A, and Series B stages. Define Ventures is renowned for their hands-on approach, providing not just capital but also strategic guidance and industry expertise to help their portfolio companies thrive. The team is led by industry veterans like Lynne Chou O'Keefe, the founder and managing partner, whose vision drives the firm's success. Other key members include A.G. Breitenstein and Frank Williams, both of whom bring extensive experience in healthcare and digital innovation. Define Ventures has recently closed $460 million across Fund III and an Opportunities Fund, cementing its position as a significant player in digital health investment.

Defy Ventures, a New York-based venture capital firm founded in 2010 by Catherine Hoke, focuses on early-stage investments and supporting entrepreneurs, particularly those with unconventional backgrounds such as former convicts. The firm is dedicated to fostering entrepreneurship, employment, and character training for its community. Defy's portfolio includes notable companies such as Nautilus Biotechnology, Empower, and Shujinko. They have made significant investments in various sectors, including high tech, business services, and food and agriculture tech. Recent investments include Monitaur, Writ, and Delivery Collective. The firm values authenticity and the tenacity needed to transform bold ideas into lasting companies. Defy Ventures aims to be the partner of choice for today's daring startup founders, helping them become tomorrow's visionary leaders. They emphasize working behind the scenes to amplify the success of their portfolio companies.

Delight Ventures is a Tokyo-based venture capital firm founded in July 2019 by Tomoko Namba, founder and chairperson of DeNA, one of Japan's leading internet companies. Originally spun out as a corporate venture unit with DeNA as its sole limited partner, the firm operates independently with investment decisions made by an autonomous team. Delight manages two funds — Fund I at approximately $100 million and Fund II at JPY 15 billion raised in 2023 — and has built a portfolio of 83 investments across Japan. The firm invests at pre-seed, seed, and Series A stages with average checks around $2 million and leads rounds. Focus sectors span AI, software, fintech, health tech, biotech, and climate tech. Portfolio companies include Matilda, Woodstock, EMLink, FundingBee, and A-SEEDS. Beyond direct investment, Delight operates a Venture Builder program that incubates companies from the ideation stage, often recruiting DeNA employees as founders and leveraging DeNA's business leaders as mentors — a structure unusual among Japanese VCs. A team of approximately 30, including seven partners, executes the firm's dual mandate across Japan and the United States. Managing Partners Tomoko Namba, Dai Watanabe, and Ryo Bando have structured the firm to pursue purely financial returns, ensuring portfolio companies maintain full optionality at exit with no obligation to align with a corporate parent's strategic agenda.

Delin Ventures is a UK-based, mission-driven venture capital firm that focuses on early-stage investments, specializing in two key areas: Life Sciences and the Future of Work & Learning. Established in 2015, the firm backs founders working on breakthrough technologies that can transform healthcare through cell therapies and the future of human work and learning. Delin invests in pre-seed and seed rounds, with typical ticket sizes ranging from €100,000 to €1.5 million, primarily in European startups. In the Life Sciences domain, Delin is committed to advancing cell therapy solutions that can either cure life-threatening diseases or transform them into manageable, chronic conditions. They also invest in the infrastructure necessary for the development and commercialization of these therapies. Notable investments include startups working on innovative therapeutics, medical services, and manufacturing technologies. In the Future of Work & Learning sector, Delin Ventures aims to unlock human potential by investing in technologies that shape the workforce of tomorrow. This includes HR tech, productivity tools, workforce development, and upskilling platforms. They provide hands-on support to founders, leveraging their deep operational expertise and extensive network. The team, led by founder Igor Linshits, includes experts from various industries, ensuring a strong focus on long-term impact. Delin's strategy is centered around making fewer, high-quality investments to ensure that they can offer exceptional support to their portfolio companies, which includes businesses like Fluidic Analytics, Vidsy, and Ori Biotech. The firm is highly selective, providing patient capital and working closely with founders to scale impactful solutions.

Delivery Hero Ventures (formerly DX Ventures) is the corporate venture capital arm of Delivery Hero SE, a publicly traded global food delivery platform headquartered in Berlin, Germany. Launched in January 2021 with initial capital of €50 million, the fund is fully backed by Delivery Hero SE and led by Managing Director Duncan McIntyre, who joined the parent company in 2014 and completed over 30 M&A transactions before leading the venture arm. The fund leads rounds and invests globally across food technology, on-demand services, AI, fintech, logistics, and sustainable innovation, writing checks averaging $5 million at Seed through Series B stages. The portfolio of 33 companies includes five unicorns, two IPOs, and three acquisitions. Notable holdings include Glovo (food delivery, acquired by Delivery Hero), Rappi (Latin American super app), Impossible Foods (plant-based meat), Ola (Indian ride-hailing), Toku (compensation management), and OneOrder (restaurant management). The fund's investment thesis centers on leveraging Delivery Hero's technical expertise and global network — spanning Europe, Southeast Asia, MENA, and Latin America — to help founders scale. Partner Brendon Blacker works alongside McIntyre to evaluate opportunities and support portfolio growth, with the team taking an engaged post-investment role in business development and market expansion.

Dell Technologies Capital (DTC) is the venture capital investment arm of Dell Technologies, focusing on early-stage investments in the enterprise technology space. Since its inception in 2012, DTC has invested in over 150 companies, helping to propel innovations in data and analytics, cybersecurity, infrastructure, developer tools, and silicon. Their notable portfolio includes industry leaders like DocuSign, MongoDB, and Cylance​. DTC’s investment strategy is to partner with founders from the early stages and provide not only capital but also deep domain expertise and operational support. The firm’s extensive network within Dell Technologies offers startups real customer connections and the opportunity to scale with the backing of a tech giant. Investments typically range from seed to growth stages, with DTC often leading the rounds​. Headquartered in Palo Alto, California, DTC’s team of investors, technologists, and operators work closely with portfolio companies, guiding them from inception to market leadership. This hands-on approach ensures that the startups benefit from strategic insights and operational know-how, positioning them for successful exits​​. Overall, Dell Technologies Capital stands out for its commitment to fostering groundbreaking enterprise technologies and its robust support system for startups aiming to disrupt the tech landscape.

Delphi Ventures, founded in 1988, is a venture capital firm based in San Mateo, California. The firm focuses primarily on life sciences, including biotechnology, medical devices, and healthcare IT. Over the years, Delphi Ventures has made significant contributions to the life sciences industry with over 318 investments and 190 exits. Notable investments by Delphi Ventures include Revance Therapeutics, Senseonics, and PTC Therapeutics. These companies have developed innovative solutions in neurotoxin aesthetics, continuous glucose monitoring, and treatments for rare diseases, respectively. Revance Therapeutics, for instance, is now a public company with significant revenue, reflecting Delphi Ventures' ability to identify and nurture high-potential startups. Delphi Ventures' investment strategy is centered on early and growth-stage investments, with a focus on supporting pioneering technologies and therapies. The firm has a strong track record of successful exits, including companies that have gone public such as EBR Systems and Senseonics, as well as several notable acquisitions like Seattle Genetics and Acclarent. The team at Delphi Ventures is led by experienced professionals such as Deepa Pakianathan, Douglas Roeder, and founder James Bochnowski. Their expertise and deep industry knowledge play a critical role in guiding portfolio companies toward successful growth and market leadership.

Delta Blockchain Fund is an early-stage venture capital firm launched in 2021 by Kavita Gupta, a seasoned investor with experience at the World Bank, IFC, and ConsenSys. The fund focuses on investing in cutting-edge blockchain technologies, backing projects across decentralized finance (DeFi), NFTs, blockchain gaming, and cross-chain analytics. Delta’s mission is to empower developers and visionaries who are building real-world use cases for blockchain, with a strong emphasis on decentralization, privacy, and financial inclusivity. The fund primarily targets pre-seed and seed-stage companies, providing strategic support to early-stage ventures that are pushing the boundaries of blockchain innovation. Portfolio companies include sector-defining names like Polygon, Starkware, Quantstamp, and Sorare, highlighting Delta's role in shaping the future of the decentralized ecosystem. In addition to venture capital, Delta Blockchain Fund also engages in DeFi and staking through its Delta Liquid Fund. Kavita Gupta leads a diverse team of experts in blockchain technology, cybersecurity, and DeFi, leveraging their extensive networks to provide both capital and mentorship to portfolio companies. The fund is dedicated to fostering innovation that reshapes the internet into a decentralized, more inclusive environment.

Delta Partners is a Dublin-based venture capital firm specializing in early-stage investments in technology companies. Founded in 1994, the firm has a strong track record with over 140 investments and €1.8 billion in exit returns. Delta Partners focuses on seed and Series A investments, supporting companies from their foundation stage through to successful scaling and exits. They emphasize building solid company foundations and capital-optimizing cultures to increase the likelihood of success. The Delta team includes experienced partners like Dermot Berkery, Maurice Roche, Amy Neale (formerly of Mastercard), and Richard Barnwell (founder of Digit Games). They are committed to integrating sustainability risks into their investment process, ensuring that environmental, social, and governance (ESG) factors are considered throughout the lifecycle of their investments. Delta Partners operates with a partner-led approach, providing startups with direct access to senior-level experience from the first conversation. This hands-on support helps entrepreneurs navigate their journey from seed to Series A and beyond.

Deltag Venture is a forward-thinking company that specializes in business solutions aimed at empowering entrepreneurs, startups, and established companies alike. With a focus on innovation, Deltag Venture helps clients navigate the complexities of today’s ever-evolving business landscape, offering tailored strategies that foster growth, efficiency, and sustainability. One of the core strengths of Deltag Venture lies in its diverse portfolio of services. From business consulting and financial planning to technological solutions and digital transformation, the company provides a comprehensive suite of tools designed to address the unique needs of each client. By leveraging data-driven insights and industry expertise, Deltag Venture delivers actionable strategies that improve decision-making and optimize operations. A significant feature that sets Deltag Venture apart is its commitment to fostering long-term relationships with clients. The company emphasizes collaboration and transparency, ensuring that businesses are supported not just in the short term but over the course of their entire growth journey. Whether a company is looking to enter new markets, streamline processes, or adopt cutting-edge technology, Deltag Venture provides the resources and guidance needed to succeed. Moreover, Deltag Venture is dedicated to staying at the forefront of industry trends, ensuring that clients benefit from the latest innovations in business strategy and technology. With a focus on delivering measurable results, the company continues to be a trusted partner for businesses looking to achieve lasting success.

Demeter, a major European player in venture capital, private equity, and infrastructure, focuses on investments that drive the energy and ecological transition. Founded in 2005, Demeter manages €1.3 billion across its funds and has completed over 230 investments. The firm targets innovative startups, SMEs, and infrastructure projects, offering investments ranging from €1 million to €30 million. Notable investments include McPhy Energy, which specializes in hydrogen production, storage, and distribution technologies, and Ynsect, which produces environmentally friendly insect-based products. Demeter also supports companies like Sunna Design, which develops solar LED lighting solutions, and Sweetch Energy, a renewable energy firm focusing on osmotic energy. One of Demeter's significant initiatives is the recent launch of a €500 million fund in collaboration with EIT InnoEnergy. This fund aims to develop a resilient and diverse battery raw material supply chain for Europe, addressing the continent's growing demand for batteries and supporting the European Battery Alliance's goals. Demeter's investment strategy is driven by a commitment to sustainability, evident in their support for green projects like H2 Green Steel, the world's first integrated large-scale green steel plant. The firm's dedication to environmental responsibility is further reflected in their involvement in initiatives like the Climate Dividends program, which promotes sustainability across their portfolio companies.

Dentsu Ventures is the corporate venture capital arm of Dentsu Group, one of the world's largest advertising and marketing conglomerates. Founded in April 2015 and headquartered in Tokyo, Japan, the firm operates two funds totaling 20 billion yen (approximately $134 million): Global Fund I covering 2015 to 2025 and Fund II launched in 2021 with a ten-year life. Managing Partner Kotaro Sasamoto leads a team that includes General Partners Daiji Horibe, Kevin Hasegawa, and Daisuke Takemori. With 65 investments across the US, Europe, and Asia-Pacific, Dentsu Ventures backs companies from Seed through late stage in AI, advertising and marketing technology, media and entertainment, biotech, data analytics, and VR/AR. The portfolio has produced three unicorns, two IPOs, and 12 acquisitions. Notable investments include Mysten Labs (blockchain), GRAIL (cancer detection, acquired by Illumina), Twist Bioscience (synthetic biology, IPO), Kognitos (enterprise AI automation), and Skyflow (data privacy). Dentsu Ventures differentiates from independent VCs by offering portfolio companies direct access to Dentsu Group's global marketing capabilities, client relationships, and co-creation resources. Startups gain the dual benefit of financial backing and commercial acceleration through one of the world's most extensive advertising networks, making the firm particularly valuable to companies building in consumer-facing and enterprise software categories.

Deosai Ventures is an early-stage, sector-agnostic venture capital fund based in Islamabad, Pakistan, founded around 2020. The fund is led by Managing Partner Shehryar Hydri, who also serves as Managing Director of Endeavor Pakistan and is a former founder himself. Deosai operates with the explicit policy of requiring no warm introductions, lowering barriers for founders who lack established networks. The fund writes checks between $50,000 and $300,000 — with a sweet spot at $200,000 — targeting pre-seed and seed-stage companies across AI, SaaS, agritech, fintech, transportation technology, logistics, developer tools, and supply chain tech. With 10 investments to date, portfolio companies include Farmdar (agritech, $1.3 million Seed in 2022), Metric, Truck It In (digital trucking), CreditPer (Shariah-compliant microfinance), Inventhub (hardware design collaboration), and EasyFresh Technologies. Hydri is known for backing diverse and female founders, and the fund covers startups with connections to UAE and US markets alongside Pakistan-focused businesses. The firm operates at a scale appropriate to Pakistan's early-stage ecosystem, combining the conviction of a hands-on founding-stage investor with broad sectoral flexibility. Deosai represents one of the few institutional pre-seed funds actively building the Pakistani startup ecosystem from Islamabad rather than from Karachi or overseas.

DEPO Ventures is a Prague-based venture capital firm founded in 2016 by Michal Ciffra and Petr Šíma, operating what it describes as the largest angel fund in the Central and Eastern Europe region. The third fund, opened in 2022, targets €20 million. DEPO's mission is to transform the CEE tech ecosystem by backing pre-seed founders from Central and Eastern Europe with global ambitions, screening more than 2,000 deals annually across 53 portfolio companies. The firm leads rounds at pre-seed stage with typical check sizes between €100,000 and €500,000, investing at valuations up to €3 million. Portfolio companies include Tatum, Spendee, Readmio, Kardi AI, Eterny, and Blockmate, spanning deep tech, fintech, software, and SaaS. DEPO also manages The DEPO Angels, an international syndicate of 200-plus business angels that co-invests alongside the fund. Venture partners include Pavel Kučera (ex-CTO of Avast), Oldřích Muller (ex-AVG and Socialbakers), Tobiáš Rataj (ex-UIPath and Rossum), and Tomáš Polcar (Professor at Czech Technical University), giving portfolio companies access to operators who have built and scaled significant European technology businesses. DEPO also organizes ENGAGED INVESTMENTS, a leading VC conference for CEE investors and founders, reinforcing its position at the center of the regional startup ecosystem.

Derayah Ventures is a Saudi-based venture capital firm that invests in early to growth-stage startups across the MENA region. Launched in 2019, the firm manages a $30 million fund focused on technology-driven businesses, particularly in sectors such as SaaS, fintech, eCommerce, artificial intelligence, Internet of Things (IoT), and marketplace platforms. Derayah primarily backs companies that are either disrupting traditional industries or organizing them through innovative solutions. The firm’s investment philosophy centers on supporting scalable startups with high growth potential and strong teams. Derayah Venture Capital provides not just financial backing but also strategic guidance to help companies expand within the MENA region, especially into Saudi Arabia. The fund focuses on post-seed, pre-Series A, and Series A stages, enabling startups to access critical capital during their early development phases. Led by a team of experienced investors, including Chairman Faris Ibrahim AlRashed, Derayah aims to build tomorrow's market leaders through a combination of capital, industry expertise, and strong local networks.

Designer Fund is a San Francisco-based venture capital firm founded by Ben Blumenrose and Enrique Allen, specializing in seed-stage investments in design-led startups. Notable investments include Omada Health, Gusto, and Stripe, companies recognized for their innovative design approaches and user-friendly interfaces. The fund primarily targets industries like financial services, healthcare, and sustainability, aiming to replace legacy systems with more efficient, user-centered solutions. Designer Fund focuses geographically on the US, with a strong presence in the Bay Area. Their strategy involves making significant contributions to seed rounds, typically around $500,000, while often not leading. They invest in about eight companies annually, allowing them to provide extensive design support through their Designer Fund Partnership. This support includes monthly design sessions, professional development workshops, and access to a community of top designers and founders. The team at Designer Fund is led by seasoned experts like Blumenrose, with extensive experience at Meta, and Allen, who has a background with Facebook’s fbFund and 500 Startups. Their collaborative approach and deep integration within the design community make them a valuable partner for startups aiming to scale their design capabilities and impact.

Detroit Venture Partners (DVP), founded in 2010 by Dan Gilbert, is a venture capital firm committed to backing early-stage tech startups that aim to drive innovation and economic growth. Based in Detroit, DVP is part of the broader Rock Family of Companies, which includes Rocket Companies, Bedrock Detroit, and the Cleveland Cavaliers. This extensive network enables DVP to offer its portfolio companies not only financial backing but also strategic partnerships and resources to help them scale effectively. DVP focuses on investing in startups that embody creativity, grit, and passion. They have a strong emphasis on companies in the technology sector, including fintech, SaaS, and logistics. Some of their notable portfolio companies include StockX, Livegistics, 100 Thieves, and CoverTree. By fostering innovation, DVP contributes to Detroit’s entrepreneurial ecosystem, helping to rejuvenate the city’s long history of industrial innovation. In addition to their investment activities, DVP runs a Summer Fellowship program that offers MBA and undergraduate students hands-on experience in venture capital and early-stage startups.

Beyond1435 is Deutsche Bahn's venture capital initiative that focuses on fostering innovation in the transportation and mobility sectors. Emerging from DB Digital Ventures in 2016, Beyond1435 has established itself as a key player in driving the future of rail and mobility technologies. The platform is dedicated to identifying and investing in early-stage startups that offer transformative solutions in areas like sustainability, production, and digital services. The firm partners with startups to develop technologies that align with Deutsche Bahn’s long-term goals of modernizing rail transport and enhancing operational efficiency. Beyond1435 supports startups through investment, collaboration, and access to Deutsche Bahn’s extensive global network. The firm focuses on technologies related to artificial intelligence, IoT, mobility, and smart cities. By fostering collaborations with external companies and setting up joint ventures, Beyond1435 strengthens not only Deutsche Bahn but also the wider mobility ecosystem. Its broad portfolio includes companies such as Brighter AI, Gideon Brothers, and Skyports, reflecting its commitment to advancing innovative technologies across sectors.

Deutsche Bank Corporate Venture Capital (CVC) is the global corporate venture program of Deutsche Bank AG, one of the world's leading financial institutions. Launched in 2020 with offices in Frankfurt, New York, and Berlin, the program is led by Jörg Landsch — Head of Central Corporate Venture Capital and a Deutsche Bank veteran since 2001 — alongside team member Milos Spiridnovic. The CVC takes strategic minority positions in early growth-stage companies, with average checks between $1 million and $10 million. With 44 investments and 12 exits to date, the portfolio concentrates on fintech, AI, ESG technology, cybersecurity, and cloud software. Notable portfolio companies include Deel (global HR and payroll platform), Kodex AI (financial data analytics), Plan A (carbon accounting), Akeyless (identity security), Axoni (distributed ledger infrastructure for capital markets), and Binalyze (digital forensics). Deutsche Bank is also an LP in High-Tech Gründerfonds, the German seed-stage fund. The CVC's investment thesis is explicitly strategic: Deutsche Bank targets companies that use technology to support or enable banking and financial services, as well as broader enterprise technology. AI and ESG are the two largest priority areas. The program partners with innovative startups to shape the future of financial services, giving portfolio companies access to Deutsche Bank's global client relationships and regulatory expertise alongside the capital investment.

DTCP (Digital Transformation Capital Partners) is an independent investment management firm founded in 2015. The firm focuses on two main investment strategies: Growth Equity and Digital Infrastructure. With over €2.2 billion in assets under management, DTCP has invested in more than 60 companies, supporting transformative technology leaders globally and digital infrastructure projects in Europe. DTCP's Growth Equity platform targets technology sectors such as cybersecurity, AI, fintech, and cloud-based enterprise software, aiming to accelerate digital transformation. Their notable portfolio includes investments in companies like Aryaka, NS1, and Heap. The firm’s data-driven investment approach and strong operational support help these companies scale effectively. In the Digital Infrastructure space, DTCP invests in mobile towers, fiber networks, and data centers. Key infrastructure investments include Swiss Towers, Community Fibre Limited, and Cellnex Netherlands. This strategy focuses on creating long-term value and supporting sustainable digital infrastructure development across Europe. The leadership team is headed by CEO Vicente Vento and includes Managing Partner Jack Young, who oversees the Growth platform, and Philipp von Bismarck, Managing Partner for the Digital Infrastructure Vehicle II. They bring extensive experience in technology investments and digital infrastructure projects. DTCP’s approach combines strategic capital investment with operational expertise, leveraging a strong network of industry relationships to drive growth and innovation in its portfolio companies.

Development Capital, established in 2013 and headquartered in Dublin, is an Irish growth capital fund manager focused on scaling mid-sized, profitable Irish SMEs with strong export potential. The firm typically invests between €2 million and €12 million in ambitious companies, using flexible financing structures such as equity, quasi-equity, or debt, and typically holds minority stakes with a five-year investment horizon. Development Capital is committed to supporting companies with growth strategies, ranging from international expansions to strategic acquisitions and production capacity increases. The fund’s €75 million Fund II, supported by the European Investment Fund and the Ireland Strategic Investment Fund, targets Irish SMEs poised for international growth. Notable portfolio companies include Version 1, a leading IT services provider, and Spotlight Oral Care, a premium oral care brand. Through their investments, Development Capital has helped companies like Perigord expand globally and develop new products. Perigord, a leader in life sciences packaging, was acquired by Tech Mahindra, allowing Development Capital to successfully exit its investment. The firm prides itself on offering more than just capital. It partners closely with management teams to maximize growth potential, bringing industry experience and market insights to every engagement. With a focus on responsible investing, Development Capital integrates ESG factors throughout its investment process, ensuring sustainable and impactful growth for its portfolio companies.

Devlabs is a micro venture capital firm with a focus on early-stage investments in North America, South America, and the Caribbean. Established in 2013 and headquartered in Oakland, California, and Temuco, Chile, Devlabs manages an $8 million fund dedicated to pre-seed investments in software startups, with plans to close a $21 million fund for agriculture and renewable energy sectors​. The firm typically invests between $100,000 and $300,000 per company in exchange for 5-15% equity, targeting industries such as B2B software in agri-business, finance, health, tourism, education, and operations​. Devlabs focuses on high-impact, high-growth tech entrepreneurs, especially those addressing multi-billion dollar problems with market-driven solutions. Devlabs was co-founded by Jose D Lopez and Ruben Hernandez, both of whom bring over 20 years of experience in venture capital, software development, and business innovation​ (devlabs)​. The firm leverages its extensive network and experience in emerging markets to reduce barriers and costs for investment, aiming to support lean, early-stage companies and help them scale rapidly.

Dexcel Pharma is the largest private pharmaceutical company in Israel, renowned for its extensive portfolio of branded and generic drugs. Founded in 1968, the company has grown into a global player, with state-of-the-art R&D and manufacturing facilities that support the development and commercialization of innovative and cost-effective pharmaceutical products. Dexcel's product portfolio spans across various therapeutic areas, including small molecules, biologics, and RNA-based therapies. The company is committed to advancing science through substantial investments in R&D, particularly in cutting-edge fields like siRNA therapeutics and oligonucleotides. Their innovation initiatives include the creation of specialized entities like Dexoligo Therapeutics, which focuses on RNA-based medicines, and Clexio Biosciences, which develops treatments for neurological and psychiatric conditions. With over 1,200 employees and a strong presence in key markets like the United States, Germany, and the UK, Dexcel manufactures over 5 billion oral-solid dosages annually. The company maintains a reputation for quality, with its facilities meeting global standards and holding approvals from regulatory bodies like the FDA and EMA.

DFS Lab, founded in 2016 and based in San Francisco, focuses on early-stage investments in technology startups across Africa. Their portfolio includes over 30 companies, with a strong emphasis on digital commerce and financial inclusion. Notable investments include startups like PayDay, CutStruct, and Terraa, which span various sectors such as fintech, logistics, and food processing. The firm invests early and provides comprehensive support to its portfolio companies, aiming to leverage technology to transform everyday commerce in Africa. Their investment strategy is research-driven, focusing on both the digital and physical hybrid nature of African markets. This approach allows them to tailor their support to the unique challenges and opportunities in these markets. DFS Lab is led by Jake Kendall and Stephen Deng, who bring extensive experience in finance, technology, and emerging markets. The team also includes experts like Juliet Maina and Joseph Benson-Aruna, who focus on policy research and entrepreneurial support respectively. The firm actively collaborates with co-investors like Ventures Platform, Seedstars, and Techstars, further strengthening their network and resource pool for portfolio companies​.

DG Daiwa Ventures, a Tokyo-based venture capital firm founded in 2016, is a joint venture between Digital Garage and Daiwa Securities Group. The fund focuses on early-stage investments in cutting-edge technologies, such as blockchain, artificial intelligence (AI), cybersecurity, biohealth, and extended reality (xR). DG Daiwa Ventures operates globally, with a special emphasis on startups in Japan and the broader Asia-Pacific region. The firm manages two main funds: DG Lab Fund I and DG Lab Fund II, which collectively manage over 20 billion yen. These funds target high-potential tech startups by leveraging the combined expertise and incubation capabilities of both Digital Garage and Daiwa Securities. DG Daiwa Ventures has a track record of nurturing successful startups, such as Goodpatch and Akili Interactive Labs, which have gained recognition for their innovative products. DG Daiwa is known for supporting its portfolio companies with strategic resources and helping them scale through partnerships, additional fundraising, and IPO support. The firm aims to identify companies that can drive technological advancements and create substantial returns for investors through a global network of partners and later-stage investors.

DG Ventures (formerly DG Incubation) is the corporate venture capital arm of Digital Garage, Inc. (TSE: 4819), with dual headquarters in San Francisco and Tokyo. Founded in 2009, the firm manages approximately $600 million in assets under management, with geographic allocation across the United States (54%), Asia and India (21%), and Japan (10%), complemented by a global fund-of-funds strategy. The 14-person team, including six partners, is led by Kaoru Hayashi — co-founder of Digital Garage in 1995 — and Keith Yuki Isobe as Founder and Managing Director. DG Ventures leads rounds and has made 335 investments with an extraordinary exit record: 11 unicorns, 17 IPOs, and 39 acquisitions. The portfolio includes Twitter (pre-IPO), LinkedIn, Facebook, Coinbase, Airbnb, Twilio, GrubHub, Udemy, ThredUp, Intercom, Lime, GoJek, and MystenLabs. The firm invests from seed through late stage across fintech, AI, blockchain, SaaS, e-commerce, proptech, mobility, healthcare, and marketplace sectors. DG Ventures also co-manages DG Lab Fund II (approximately JPY 12.5 billion) with DG Daiwa Ventures targeting next-generation technology startups, and operates GenLab, a startup studio for generative AI entrepreneurs. The combination of a seasoned institutional track record, deep Japanese corporate relationships, and active US presence gives DG Ventures a distinctive cross-Pacific vantage point across its investment activity.

DGNL Ventures is an early-stage venture capital fund founded in 2016 by Desiree Gruber and Nir Liberboim, headquartered in New York City. The firm invests exclusively in the consumer sector, making minority investments in high-growth companies across consumer technology, consumer goods, and consumer media. DGNL targets post-revenue companies with at least $1 million in sales, demonstrated product-market fit, retail distribution, and strong founding teams. Gruber also serves as CEO of Full Picture, a media and entertainment firm, giving the partnership direct industry relationships. With 27 investments to date, DGNL writes checks between $500,000 and $3 million at Seed and Series A stages. The portfolio spans food and beverage (Banza, Magic Spoon, Icelandic Provisions, Just Water), beauty and personal care (Fekkai, Moon Juice, Wander Beauty), health and wellness (Maven Clinic, Ladder, The Well), fashion (Sarah Flint), and consumer technology (Quip). Maven Clinic reached unicorn status in 2021, and the portfolio has generated nine acquisitions including Sir Kensington's and Brava Home. DGNL's investment philosophy centers on backing distinctive brands founded by differentiated operators who are disrupting traditional categories with new business models. The firm looks for founders who understand both the product and the consumer deeply, then applies its media and entertainment relationships to accelerate brand reach and retail distribution — a value-add that extends well beyond the initial check.

DHS Venture Partners is a Stockholm-based angel investment collective founded in 2015, composed of approximately 25 selected venture partners drawn from the alumni network of the Stockholm School of Economics (DHS stands for Diplomerad från Handelshögskolan i Stockholm). The partners — founders, operators, and experienced investors — invest as individuals while supporting portfolio companies as a coordinated collective backed by an extended alumni network of over 120 investments. The collective focuses almost exclusively on Swedish pre-seed and seed-stage startups, writing checks between approximately €240,000 and €700,000. With 32 investments across fintech, AI, foodtech, cleantech, healthtech, and marketplace sectors, the portfolio includes Karma (food waste marketplace), Treyd (B2B lending fintech), Lassie (pet insurance), Blykalla (small modular reactors), Airinum (air pollution protection), and Validio (big data monitoring). Three exits have been recorded, including Insurello and Qasa (rental marketplace). Key partners include tech entrepreneur Mattias Miksche, Robin Ramm-Ericson (co-founder of LeoVegas), Alexander Paterson-Pochet (founding partner at J12 Ventures), Christine Ahlstrand (founder at Climate Correction VC), and Fredrik Posse (impact investor). The collective's combined portfolio companies represent an accumulated valuation exceeding 15 billion SEK, and partners have held board seats at firms including Altor, Kinnevik, and Nasdaq-listed businesses.

DHV Digital Health Ventures is a Berlin-based, sector-focused early-stage venture capital fund founded in 2015 by Ulli Jendrik Koop, dedicated to building a sustainable digital health ecosystem across Europe. The firm is managed by DHV Management GmbH and invests in young startups pioneering human-centric healthcare solutions primarily in Germany and other European markets, with additional activity in Scandinavia, Canada, and the US. DHV leads rounds and writes checks from $250,000 to $5 million across pre-seed through Series B stages, with approximately 10 investments and two exits to date. Portfolio companies include TeleClinic (telemedicine, acquired by Zur Rose Group in 2020), Wefight (chronic illness virtual assistant, for which DHV led an $11.8 million Series A), Liva Healthcare (digital chronic disease management used by NHS England), DrugStars (medicine review and donation platform), and Movn Health. Managing Partners Ulli Jendrik Koop, Guido Hegener (an early-stage digital health investor since 2013), and Min-Sung Sean Kim (formerly at Allianz X and Samsung Catalyst Fund) lead the investment team. DHV's investment thesis prioritizes digital health startups with attractive business models that leverage technology to improve patient outcomes. The firm draws on a strong network of experienced investors, clinicians, and healthcare operators, positioning it as more than a capital source — portfolio companies gain access to clinical validation pathways and commercial partnerships that are critical for scaling health technology businesses.

DHVC, founded in 2013 by Shoucheng Zhang, is a venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments across several sectors, including enterprise, consumer, fintech, and healthcare. Over the years, DHVC has built a substantial portfolio, investing in over 267 companies with 75 successful exits​. DHVC has also seen significant exits with companies like Wish Shopping, Qeexo, and Namocell, indicating their strong presence in the tech investment space. The firm’s investment strategy involves participating in a mix of seed, early-stage, and later-stage funding rounds, often co-investing with other prominent venture capital firms​. The DHVC team, led by key members such as Kevin Ding and Judy Yan, brings a wealth of experience and a global perspective to their investment approach. The firm’s operations are split between the United States and China, allowing them to leverage opportunities across major innovation hubs​.

Diageo is a global leader in the beverage alcohol industry, headquartered in London, UK. Established in 1997 through the merger of Guinness PLC and Grand Metropolitan, the company has grown into a powerhouse, owning a vast portfolio of iconic brands across spirits, beer, and wine. Its flagship brands include Johnnie Walker, Guinness, Tanqueray, Smirnoff, and Baileys, which are enjoyed in over 180 countries. Diageo's business model focuses on premiumization, innovation, and sustainability. It operates in three major regions: North America, Europe, and Asia-Pacific, with North America being its largest market. The company continuously invests in expanding its product lines, with a particular emphasis on premium and ultra-premium categories. In recent years, Diageo has strengthened its position in the tequila market with brands like Don Julio and Casamigos. Sustainability and social responsibility are core to Diageo’s operations. The company is committed to reducing carbon emissions, water usage, and plastic waste across its production facilities, with ambitious goals set for 2030. Additionally, Diageo has a long history of promoting responsible drinking through campaigns and partnerships worldwide. Led by CEO Ivan Menezes, Diageo continues to focus on long-term growth by exploring new markets, embracing digital innovation, and investing in a diversified portfolio of brands that cater to evolving consumer preferences. The company’s strategy combines its rich heritage with forward-thinking initiatives, solidifying its position as a global leader in the spirits industry.

Diagram is a venture capital firm and venture builder based in Montreal and Toronto, with over $350 million in assets under management. Launched in 2016, Diagram focuses on Fintech, Web3, and ClimateTech industries. It stands out for its hands-on approach, where it not only provides capital but also actively collaborates with founders to build and launch companies. Since its inception, Diagram has helped launch over 20 ventures, raising more than $500 million across its portfolio, and creating substantial shareholder value. The firm's investment model centers on early-stage companies, providing founders with access to its extensive global network of investors, operators, and industry leaders. This helps accelerate the growth and success of its portfolio companies. Notable investments in Diagram's portfolio include companies like WorkOS, Weights & Biases, and CitadelID. Diagram combines its venture building expertise with strategic investments, making it a strong player in supporting companies from idea to execution in their respective markets​.

Diamond Capital is a venture capital firm based in Taiwan, primarily focusing on investments in the biotechnology, medical, and high-tech sectors. Established in 2013, the firm has built a strong reputation for nurturing innovative companies that are driving advancements in healthcare, new drug development, high-end medical equipment, and innovative medical services. Diamond Capital is known for its strategic investments that span early to growth-stage companies, particularly those operating in Asia. The firm is particularly noted for its involvement in the biotechnology sector, where it has been instrumental in supporting startups that have gone on to achieve significant milestones, including public listings. Diamond Capital's strategy involves not only providing capital but also leveraging its extensive network and expertise to guide companies through the complexities of scaling and entering global markets. This approach has made it a key player in Taiwan’s venture capital landscape. In 2023, Diamond Capital made headlines by becoming the first biotech venture capital firm to list on the Taiwan Stock Exchange, further enhancing its visibility and credibility on the international stage. The firm's portfolio includes a diverse array of companies, from cutting-edge biotech firms to innovative medical device manufacturers, all of which are united by their potential to make significant contributions to their respective fields.

Diaspora Ventures (Diaspora.VC) is a venture capital firm that focuses on empowering entrepreneurs and startups within global diaspora communities. Their mission is to support visionary founders who leverage their unique cultural backgrounds, global perspectives, and diverse experiences to create impactful businesses. By investing in these founders, Diaspora Ventures aims to drive innovation and bridge gaps between different markets and ecosystems worldwide. The firm believes that the entrepreneurial spirit of the diaspora is key to building businesses that not only thrive locally but also have a global impact. Diaspora Ventures provides startups with the capital, mentorship, and network connections they need to scale their operations. Whether a company is targeting underrepresented markets, solving global challenges, or expanding into new regions, the firm’s goal is to support founders with a unique edge in the competitive business landscape. Diaspora Ventures stands out for its focus on diversity, inclusion, and global reach. It actively seeks out founders who often lack access to traditional venture capital due to geographic or cultural barriers. By doing so, they help level the playing field for entrepreneurs who can offer new, transformative solutions across a wide range of industries including technology, healthcare, fintech, and more. Through their investments, Diaspora Ventures not only fosters economic growth but also promotes social change by supporting companies that are rooted in the values of inclusivity, cross-cultural understanding, and global collaboration. This makes them a strategic partner for entrepreneurs looking to make a meaningful, lasting impact.

DIC Corporation operates a Corporate Venture Capital (CVC) unit that focuses on strategic investments aligned with their core mission of sustainable innovation. Founded as a global leader in fine chemicals, DIC leverages its venture capital arm to support startups that bring new, disruptive technologies in areas like biomanufacturing, advanced materials, and industrial IT. Their investment strategy aims to complement their existing businesses in sectors such as color science, healthcare, and packaging. Recent notable investments include funding Debut Biotechnology, a California-based company specializing in sustainable biomanufacturing. This partnership allows DIC to accelerate the development of bio-based materials, particularly natural pigments for cosmetics and nutrition, aligning with their long-term vision of sustainability under the DIC Vision 2030 plan. DIC's CVC activities also extend to partnerships with other venture funds, such as their collaboration with Emerald Technology Ventures, which focuses on industrial innovation in clean technology. DIC’s strategic approach to venture investing helps them explore new markets while enhancing their capabilities in sustainable products, driving innovation across their global network of over 190 companies.

Diehl Ventures GmbH is a corporate venture capital subsidiary of the Diehl Group, a German industrial conglomerate. Founded in December 2015 and headquartered in Nuremberg, Germany, Diehl Ventures invests in technology-driven startups with growth potential aligned with the Diehl Group's five divisions: Metall, Controls, Defence, Aviation, and Metering. Managing Director Mathias Glasmacher leads the operation, which coordinates closely with the parent company's operative business units to create industrial synergies. The firm has executed more than 20 deals at Seed and Series A stages, writing checks between $250,000 and $5 million. Diehl Ventures focuses on nine technology themes including materials and production technologies, energy storage and conversion, IoT, cybersecurity, data analysis, aircraft cabin technologies, and platform-based business models. Portfolio companies include Walaris (AI-powered drone detection and airspace security), Symvaro (smart city and digital water economy), Rockethome (energy IoT and smart home solutions), and Auterion (drone and robotics software platform). As a strategic investor, Diehl Ventures gives portfolio companies access to the Diehl Group's extensive network of industrial customers and suppliers, offering commercial validation opportunities that are particularly valuable for deep tech and hardware-oriented startups. The firm focuses primarily on European companies, with particular emphasis on the German market, and aims to find opportunities where the parent group's domain expertise translates into measurable competitive advantage for the investee.

Differential Ventures is a seed-stage venture capital fund founded by data scientists and entrepreneurs, with a focus on investing in B2B, data-centric technology startups. Notable investments include companies like Private AI, Ocrolus, and Agnostiq, which are at the forefront of AI, machine learning, and quantum computing. The fund primarily targets enterprises that leverage data to transform business operations, with significant investments in AI-powered business solutions, cybersecurity, and fintech. Geographically, Differential Ventures is based in New York but maintains a broad investment horizon, with portfolio companies spread across North America. Their strategy emphasizes early-stage investments, typically writing checks between $250,000 and $1 million, and they often lead funding rounds. The firm is proactive in offering guidance to portfolio companies, drawing on their deep expertise in data science and entrepreneurial ventures. Key team members include Nick Adams, co-founder and managing partner, known for his hands-on approach and operational insights, and David Magerman, a managing partner who brings extensive experience in AI and machine learning operations. Differential Ventures is known for its active involvement in the tech community, hosting webinars and engaging in discussions about AI policy and its implications for industry and society. For startups seeking investment, approaching Differential Ventures with a well-defined data-driven strategy and a scalable business model is crucial.

DCP Capital is a private equity firm based in Beijing, China, founded in 2017 by Julian Wolhardt and David Liu. The firm focuses on investments in companies operating in sectors such as healthcare devices, semiconductors, commercial services, agriculture, and manufacturing across Mainland China, Hong Kong, Macau, and Taiwan. Notable investments by DCP Capital include Jamieson Wellness, a leading consumer health brand; Mengniu Dairy, one of China’s largest dairy producers; and 51job, a major recruitment website in China, which was acquired for $3.8 billion. The firm has also invested in innovative companies like Broncus Medical, Venus MedTech, and Fenbi, which focuses on education and training services. DCP Capital manages assets of over $2.5 billion, having recently completed the first close of their second China fund. This fund aims to invest in early and growth-stage companies, furthering their mission to support transformative businesses in the region.